Désiré Collen
Founder at Life Sciences Research Partners VZW
Network origin in Désiré Collen first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
17
| Public Company | Pharmaceuticals: Major | 17 |
Life Sciences Research Partners VZW
 Life Sciences Research Partners VZW Investment Trusts/Mutual FundsMiscellaneous Life Sciences Research Partners VZW functions as a foundation or endowment. The non-profit company is based in Leuven, Belgium. The Belgian company was founded by Désiré Collen.
2
| Non-Profit Organization | Investment Trusts/Mutual Funds | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Désiré Collen via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| GOLDEN QUEEN MINING CONSOLIDATED LTD. | Precious Metals | Director/Board Member Chief Executive Officer | |
Johnson & Johnson Innovation - JJDC, Inc.
 Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Investment Managers | Corporate Officer/Principal | |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Medical Specialties | Corporate Officer/Principal | |
Dr. Reddy's Research & Development BV
 Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Chairman | |
| University of Leeds | College/University | Undergraduate Degree | |
| Fairleigh Dickinson University | College/University | Undergraduate Degree | |
Arradiance LLC
 Arradiance LLC SemiconductorsElectronic Technology Arradiance LLC develops maskless, massively parallel and direct-write e-beam source products. It combines material science, charged particle physics, equipment design, modeling, simulation and vacuum technology. The company was founded by Harry F. Lockwood, Kenneth Stenton and David R. Beaulieu in 2003 and is headquartered in Sudbury, MA. | Semiconductors | Chairman Chairman | |
Eli Lilly & Co. Ltd.
 Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Eli Lilly & Co. Ltd. provides pharmaceutical health care solutions. It provide products for cardiovascular, dermatology, diabetes, endocrine, musculoskeletal, neuroscience, oncology and urology. The company was incorporated on April 9, 1963 and is headquartered in Basingstoke, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
East Hill Management Co. LLC
 East Hill Management Co. LLC Investment ManagersFinance East Hill Management Co. LLC (East Hill Management) is a venture capital firm founded in 2000 by Landon Thomas Clay and Jeffrey Scott Garner. The firm is headquartered in Providence, Rhode Island. | Investment Managers | Founder Private Equity Investor | |
| Katholieke Universiteit Leuven | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree | |
Ogeda SA
 Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Pharmaceuticals: Major | Director/Board Member | |
| Umea Universitet | College/University | Doctorate Degree | |
| Vlerick Leuven Gent Management School | College/University | Masters Business Admin Masters Business Admin | |
Vlaams Instituut voor Biotechnologie - Flanders Institute
 Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | College/University | Director/Board Member | |
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member Chairman | |
| Clay Mathematics Institute | College/University | Founder Director/Board Member | |
Janssen Pharmaceutica NV
 Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Pharmaceuticals: Major | Chief Executive Officer | |
| The Janssen Research Foundation | President Director/Board Member | ||
| East Hill Advisors LLC | Founder Corporate Officer/Principal | ||
FlandersBio vzw
 FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Miscellaneous Commercial Services | Chairman Chairman Founder | |
Biocartis SA
 Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Medical Specialties | Director/Board Member | |
| SENSORION | Pharmaceuticals: Major | Director/Board Member | |
Amakem NV
 Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | Medical/Nursing Services | Chairman Chief Tech/Sci/R&D Officer Director/Board Member | |
| ViBio BVBA | Director/Board Member | ||
| Het Vlaams Parlement | Corporate Officer/Principal Corporate Officer/Principal | ||
| Viziphar Biosciences BV | Chief Executive Officer | ||
| Vivactis NV | Miscellaneous | Director/Board Member | |
| University of Antwerp | College/University | Graduate Degree Graduate Degree | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| PROQR THERAPEUTICS N.V. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| BIOCARTIS GROUP NV | Medical Specialties | Director/Board Member | |
DoseVue NV
 DoseVue NV Medical SpecialtiesHealth Technology DoseVue NV is developing innovative technologies for convenient and accurate in-vivo dosimetry. It offers DoseWire Series 100 & DoseWire Series 200. The company was founded by Emiliano D Agostino in March 2013 and is headquartered in Turnhout, Belgium. | Medical Specialties | Chairman | |
Flanders Make VZW
 Flanders Make VZW Miscellaneous Commercial ServicesCommercial Services Flanders Make VZW is a strategic research center for the manufacturing industry. Flanders Make is based in Lommel, BE. The Belgian company stimulates open innovation through high-quality research and customized collaborations. The CEO of the private company is Dirk Torfs. | Miscellaneous Commercial Services | Director/Board Member | |
Wewatt BV
 Wewatt BV Wholesale DistributorsDistribution Services Wewatt Bvba is a Belgian company that specializes in converting human kinetic energy into usable power. The private company is based in Leuven, Belgium and was founded by Patricia Ceysens. The company offers a unique experience to their customers by allowing them to pedal power a table to charge and share their own energy. | Wholesale Distributors | Founder | |
| IMMUNOPRECISE ANTIBODIES LTD. | Biotechnology | Director/Board Member | |
Becommerce
 Becommerce Internet Software/ServicesTechnology Services Becommerce is a non-profit organization based in Belgium that brings together companies in the Belgian market for digital trade. The organization actively works towards uniting these companies and promoting digital commerce. | Internet Software/Services | Director/Board Member | |
| CoBioRes NV | Director/Board Member | ||
EyeD Pharma SA
 EyeD Pharma SA Medical SpecialtiesHealth Technology EyeD Pharma SA manufactures and supplies ophthalmology surgical products. Its products include R&D, instrumentation and phaco accessories. The company was founded by Jean-Marie Rakic and Jean-Michel Foidart and is headquartered in Liege, Belgium. | Medical Specialties | Director/Board Member | |
| HYLORIS PHARMACEUTICALS SA | Pharmaceuticals: Major | Director/Board Member | |
Patcobel NV
 Patcobel NV Real Estate DevelopmentFinance Patcobel NV provides real estate services. The private company is based in Kortrijk, Belgium. The CEOs are Cindy van Loock and Patrick Lippens. The Belgian company was founded in 1989. | Real Estate Development | Director/Board Member | |
DeuterOncology SA
 DeuterOncology SA BiotechnologyHealth Technology DeuterOncology SA is a Belgian preclinical-stage biotechnology company that specializes in developing targeted cancer therapies. DeuterOncology is based in Liege, BE. The company's focus is on creating a first-in-class dual MET and RAS pathway inhibitor. The company was founded in 2020 by Timothy Perera, who has been the CEO since 2020. | Biotechnology | Chairman | |
Cellaïon SA
 Cellaïon SA BiotechnologyHealth Technology Cellaïon SA is a biotech company located in Mont Saint Guibert, Belgium. Cellaïon aims to restore a favorable environment to reboost the regenerative process of the liver and ensure a second life to the native liver instead of losing it. The Belgian company has a strong IP base issued from their own research and academic research at UCLouvain, developed with the objective to generate new products. Cellaïon's treatment covers the wide spectrum of liver diseases, from the highly life-threatening acute-on-chronic liver-failure (ACLF) and acute alcoholic hepatitis, to intermediate severity acute decompensation of cirrhosis (AD) and progressive chronic liver diseases caused by non-alcoholic steatohepatitis (NASH). The company has built up a series of R&D and collaborative partnerships with both industrial and academic partners, allowing Cellaïon to broaden and accelerate its clinical development. The company was founded by Etienne Marc Sokal, who has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
| Louis Jeantet Foundation | Director/Board Member | ||
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Miscellaneous Commercial Services | Chairman Chief Tech/Sci/R&D Officer |
Statistics
International
| Belgium | 30 |
| United States | 12 |
| Canada | 3 |
| Netherlands | 3 |
| United Kingdom | 3 |
Sectoral
| Health Technology | 22 |
| Consumer Services | 10 |
| Commercial Services | 5 |
| Finance | 4 |
| Non-Energy Minerals | 2 |
Operational
| Director/Board Member | 71 |
| Corporate Officer/Principal | 28 |
| Chairman | 23 |
| Chief Tech/Sci/R&D Officer | 16 |
| Independent Dir/Board Member | 15 |
Most connected contacts
| Insiders | |
|---|---|
| Chris Buyse | 39 |
| Staf van Reet | 22 |
| Landon Clay | 19 |
| Paul Howes | 15 |
| Randall Moreadith | 13 |
| Thomas Moragne Clay | 10 |
| Patrik de Haes | 9 |
| Stephen Pakola | 8 |
| Aniz Girach | 7 |
| Stuart Laermer | 6 |
| Jean Marie Stassen | 6 |
| Andy de Deene | 6 |
| Patricia Ceysens | 6 |
| Christian Jaeggi | 3 |
| Wouter Piepers | 2 |
- Stock Market
- Insiders
- Désiré Collen
- Company connections
